Radiothérapie externe des carcinomes hépatocellulaires

Llovet, 2003, Hepatocellular carcinoma, Lancet, 362, 1907, 10.1016/S0140-6736(03)14964-1 De Bari, 2010, Dose de tolérance à l’irradiation des tissus sains : le foie, Cancer Radiother, 14, 344, 10.1016/j.canrad.2010.02.013 Merle, 2011, Chimioembolisation et radiothérapie de conformation dans le traitement du carcinome hépatocellulaire, Cancer Radiother, 15, 49, 10.1016/j.canrad.2010.11.001 Bujold, 2011, Stereotactic radiation therapy and selective internal radiation therapy for hepatocellular carcinoma, Cancer Radiother, 15, 54, 10.1016/j.canrad.2010.11.003 Wang, 2000, Radiotherapy and intra-arterial chemotherapy of locally advanced hepatocellular carcinoma. Analysis of prognostic factors, Cancer Radiother, 4, 191, 10.1016/S1278-3218(00)89093-9 Wigg, 2010, Radiotherapy for hepatocellular carcinoma: systematic review of radiobiology and modeling projections indicate reconsideration of its use, J Gastroenterol Hepatol, 25, 664, 10.1111/j.1440-1746.2009.06126.x Kaizu, 1998, Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients, Am J Gastroenterol, 93, 2167, 10.1111/j.1572-0241.1998.00614.x Order SE, Stillwagon GB, Klein JL, Leichner PK, Siegelman SS, Fishman EK, et al. Iodine 131 anti-ferritin, a new treatment modality in hepatoma: a radiation therapy oncology Group Study. J Clin Oncol 1985;13:1573–82. Yasuda, 1999, Radiotherapy for large hepatocellular carcinoma combined with transcatheter arterial embolization and percutaneous ethanol injection therapy, Int J Oncol, 15, 467 Stillwagon, 1989, 194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response. A radiation therapy oncology group study, Int J Radiat Oncol Biol Phys, 17, 1223, 10.1016/0360-3016(89)90530-0 Dawson, 2000, Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies, J Clin Oncol, 18, 2210, 10.1200/JCO.2000.18.11.2210 Lawrence, 1993, Conformal high-dose radiation plus intraarterial floxuridine for hepatic cancer, Oncology, 7, 51 Dawson, 2005, Partial volume tolerance of the liver to radiation, Semin Radiat Oncol, 15, 279, 10.1016/j.semradonc.2005.04.005 Lawrence, 1992, The use of 3-D dose volume analysis to predict radiation hepatitis, Int J Radiat Oncol Biol Phys, 23, 781, 10.1016/0360-3016(92)90651-W Dawson, 2001, The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy, Int J Radiat Oncol Biol Phys, 51, 1410, 10.1016/S0360-3016(01)02653-0 Dawson, 2002, Analysis of radiation-induced liver disease using the Lyman NTCP model, Int J Radiat Oncol Biol Phys, 53, 810, 10.1016/S0360-3016(02)02846-8 Lawrence, 1990, An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy, Int J Radiat Oncol Biol Phys, 19, 1041, 10.1016/0360-3016(90)90031-E Lawrence, 1991, Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine, Int J Radiat Oncol Biol Phys, 20, 555, 10.1016/0360-3016(91)90069-G McGinn, 1998, Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model, J Clin Oncol, 16, 2246, 10.1200/JCO.1998.16.6.2246 Robertson, 1993, Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy, J Clin Oncol, 11, 1286, 10.1200/JCO.1993.11.7.1286 Robertson, 1997, Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers, Int J Radiat Oncol Biol Phys, 37, 325, 10.1016/S0360-3016(96)00528-7 Ben-Josef, 2005, Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies, J Clin Oncol, 23, 8739, 10.1200/JCO.2005.01.5354 Liu, 2004, Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization, Jpn J Clin Oncol, 34, 532, 10.1093/jjco/hyh089 Kim, 2006, Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable, Am J Clin Oncol, 29, 568, 10.1097/01.coc.0000239147.60196.11 Mornex, 2005, High-dose 3-dimensional radiotherapy is feasible in cirrhotic patients with small-size hepatocellular carcinoma not suitable for curative therapies, Int J Radiat Oncol Biol Phys, 15, 1152 Park, 2002, Dose-response relationship in local radiotherapy for hepatocellular carcinoma, Int J Radiat Oncol Biol Phys, 54, 150, 10.1016/S0360-3016(02)02864-X Seong, 2009, A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea, Liver Int, 29, 147, 10.1111/j.1478-3231.2008.01873.x Toya, 2007, Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma, Radiother Oncol, 84, 266, 10.1016/j.radonc.2007.07.005 Leung, 2000, Conformal radiation therapy for hepatoma with portal vein thrombosis, Br J Radiol, 73, 550, 10.1259/bjr.73.869.10884755 Cheng, 2004, Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease, Int J Radiat Oncol Biol Phys, 60, 1502, 10.1016/j.ijrobp.2004.05.048 Cheng, 2002, Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication, Int J Radiat Oncol Biol Phys, 54, 156, 10.1016/S0360-3016(02)02915-2 Cheng, 2003, Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease, Int J Radiat Oncol Biol Phys, 56, 229, 10.1016/S0360-3016(03)00091-9 Kim, 2009, Predictive factors of gastroduodenal toxicity in cirrhotic patients after three-dimensional conformal radiotherapy for hepatocellular carcinoma, Radiother Oncol, 93, 302, 10.1016/j.radonc.2009.05.017 Seong, 2009, Challenge and hope in radiotherapy of hepatocellular carcinoma, Yonsei Med J, 50, 601, 10.3349/ymj.2009.50.5.601 Zhao, 2008, Application of active breathing control in 3-dimensional conformal radiation therapy for hepatocellular carcinoma: the feasibility and benefit, Radiother Oncol, 87, 439, 10.1016/j.radonc.2007.12.006 Kubas, 2009, Impact dosimétrique du blocage respiratoire dans le traitement du carcinome hépatocellulaire par irradiation de conformation, Cancer Radiother, 13, 24, 10.1016/j.canrad.2008.09.011 Xi, 2009, How many sets of 4DCT images are sufficient to determine internal target volume for liver radiotherapy?, Radiother Oncol, 92, 255, 10.1016/j.radonc.2009.05.007 McIntosh, 2009, Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma, Cancer, 115, 5117, 10.1002/cncr.24552 Chiba, 2005, Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients, Clin Cancer Res, 11, 3799, 10.1158/1078-0432.CCR-04-1350 Hata, 2007, Proton beam therapy for aged patients with hepatocellular carcinoma, Int J Radiat Oncol Biol Phys, 69, 805, 10.1016/j.ijrobp.2007.04.016 Hata, 2006, Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis, Strahlenther Onkol, 182, 713, 10.1007/s00066-006-1564-2 Sugahara, 2010, Proton beam therapy for large hepatocellular carcinoma, Int J Radiat Oncol Biol Phys, 76, 460, 10.1016/j.ijrobp.2009.02.030 Mizumoto, 2008, Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis, Int J Radiat Oncol Biol Phys, 71, 462, 10.1016/j.ijrobp.2007.09.056 Hashimoto, 2006, Repeated proton beam therapy for hepatocellular carcinoma, Int J Radiat Oncol Biol Phys, 65, 196, 10.1016/j.ijrobp.2005.11.043 Fukumitsu, 2009, A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma, Int J Radiat Oncol Biol Phys, 74, 831, 10.1016/j.ijrobp.2008.10.073 Quivrin, 2010, Cancer Tumeurs primitives hépatiques, Cancer Radiother, 14, S103, 10.1016/S1278-3218(10)70013-5